1Cowie MR.Struthers AD,wood da.et al.Value of natrouretic peptides in assessment of patients with possible new heart failure in primary care.lancet,1997,350:1347～1351.
2Suauki T,Yamaoki K,Nakajima O,et al.Screening for cardiac dysfunction in asymptomatic patients by measure B-type natriuretic peptide levels.Jpn Heart J.2000,41:205.
3Yasue H,Yoshimura M,Sumida H,et al.Localization and mechanism of secretion of B-type natriuretic peptide copparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation.1994,90(1):195.
4Mcdonagh TA,Robb SD,Murdoch DR,et al.Biochemical detection of left ventricular system dysfunction.Lancet.1998,351:9.
5Tanaka T,Hasegawa K,Fujita M,et al.Marked elevation of brain natriuretic peptide levels in pericardial fluid is cloassociated with left ventricular dysfunction.J Am Coll Cardiol.1998,31:399.
6Friedl W,Mair J,Thomas S,et al.Natriuretic peptides and cyclic gunanosien 3'5'monophosphate in asymptomatic ventricular dysfunction.Heart.1996,76:129.
